- Report
- July 2025
- 134 Pages
Global
From €4115EUR$4,650USD£3,558GBP
- Report
- August 2025
- 193 Pages
Global
From €3137EUR$3,545USD£2,712GBP
€3485EUR$3,939USD£3,014GBP
- Report
- January 2025
- 100 Pages
Global
From €5265EUR$5,950USD£4,552GBP
- Report
- April 2025
- 175 Pages
Global
From €3973EUR$4,490USD£3,435GBP
- Report
- September 2025
- 93 Pages
Global
From €4955EUR$5,600USD£4,285GBP
- Report
- September 2025
- 382 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2655EUR$3,000USD£2,295GBP
- Report
- December 2024
- 159 Pages
Global
From €3495EUR$3,950USD£3,022GBP
- Report
- March 2025
- 180 Pages
Global
From €3982EUR$4,500USD£3,443GBP
- Report
- June 2025
- 150 Pages
Global
From €2388EUR$2,699USD£2,065GBP
- Report
- November 2024
- 39 Pages
Global
From €3535EUR$3,995USD£3,057GBP
- Report
- August 2025
- 189 Pages
Global
From €3137EUR$3,545USD£2,712GBP
€3485EUR$3,939USD£3,014GBP
- Report
- August 2025
- 191 Pages
Global
From €3137EUR$3,545USD£2,712GBP
€3485EUR$3,939USD£3,014GBP
- Report
- July 2025
- 150 Pages
Global
From €5265EUR$5,950USD£4,552GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1770EUR$2,000USD£1,530GBP
- Report
- October 2024
- 318 Pages
Global
From €7035EUR$7,950USD£6,083GBP
From €4336EUR$4,900USD£3,749GBP
- Report
- October 2024
- 200 Pages
Global
From €3318EUR$3,750USD£2,869GBP
- Report
- June 2025
- 209 Pages
Global
From €2212EUR$2,500USD£1,913GBP
- Report
- June 2025
- 400 Pages
Global
From €4379EUR$4,949USD£3,787GBP

The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more